Found 53 Publications Showing 31-40

	Hidden Harm Three Years On: Realities, Challenges and Opportunities: Executive Summary (11/02/2007) Hidden Harm's publication andd issemination generated considerable media interest and proved to be the most widely distributed ACMD report to date.
	Hidden Harm Three Years On: ACMD Press Release (09/02/2007) Hidden Harm Three Years On: ACMD Press Release
	Hidden Harm Three Years On: Realities, Challenges and Opportunities (09/02/2007) This report, in keeping with the original Hidden Harm report, focuses on the lives and experience of a large, diverse and vulnerable group of children.
	ACMD Response to the Science and Technology Committee report on drug classification (13/12/2006) The Advisory Council on the Misuse of Drugs (ACMD) was pleased to learn, in November 2005, of the decision of the House of Commons Science and Technology Committee to hold an inquiry “To examine the way in which the Government obtains and uses scientific information and uses scientific advice in the development of policy.” The Council was further encouraged by the Committee’s statement that “the inquiry will focus upon the mechanisms in place for the use of scientific advice (including the social sciences) and the way in which the guidelines governing the use of such advice is being applied in practice. It will test the extent to which policies are evidence-based.
	Khat Report 2005 (19/01/2006) The khat plant (catha edulis) originates from Ethiopia and has been used for centuries in several countries in East Africa and the Arab Peninsular around the Red Sea.
	The Advisory Council’s Report - Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971.(2005) (19/01/2006) The Advisory Council’s Report - Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971. A report from the Advisory Council following the Home Secretary’s request in March 2005.
	ACMD Annual Report 2004-2005 (19/12/2005) This is the Advisory Council's fifth Annual Report, which provides an overview of its work, in accordance with both the Cabinet Office's Code of Practice for Board Members of Non-Departmental Public Bodies and the Code of Practice for Scientific Advisory Committees. It give details of the main issues the Advisory Council considered between April 2004 - March 2005 as well as general information about its terms of reference, membership and adminstration arrangements, as well as the work of its Committees and Working Groups.
	ACMD's latest Methylamphetamine Advice (19/12/2005) The Home Secretary has accepted the ACMD's recommendation to reclassify methylamphetamine to a Class A Drug. Methylamphetamine (commonly referred to as methamphetamine or by its street name of "crystal meth" or "ice") is a member of a broad class of psycho-stimulant compounds called amphetamines, which act on the central and peripheral nervous system.
	Methylamphetamine Review (2005) (17/11/2005) Methylamphetamine (MA) is an amphetamine and is controlled as a Class B drug under the Misuse of Drugs Act 1971. MA is also known as "ice", "crystal meth" and "tina". The effects of MA are stronger and usually longer lasting than amphetamine. There is a paucity of information about the prevalence of MA use in the UK. What evidence there is suggests consumption of MA in the UK is very limited. However, given the experience of other countries such as the USA where MA misuse has become widespread the Advisory Council reviewed the harms posed by the drug now and the potential for its use to increase in the UK in the future. The Advisory Council recommended that it would be inappropiate at this stage to reclassify MA to a Class A drug. It recommended the development of an early warning system to monitor any shifts in the patterns of prevalance of MA in the UK and encouragment of further scientific and pharmacological research studies on MA to fill current gaps in research and knowledge.
	Advisory Council on the Misuse of Drugs Methylamphetamine Review 2005 Executive Summary (17/11/2005) Methylamphetamine (commonly referred to as methamphetamine) is a member of a broad class of psycho-stimulant compounds called amphetamines. Amphetamines act on the central and peripheral nervous system. In this document, ‘amphetamine’ is abbreviated as ‘AMP’ and methylamphetamine is abbreviated as ‘MA’.

Found 53 items, displaying 31 to 40.

• Page:
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• Next